Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹Başkent Üniversitesi İstanbul Hastanesi, Göz Hastalıkları A.D., İstanbul, Yrd. Doç. Dr.
²Başkent Üniversitesi İstanbul Hastanesi, Göz Hastalıkları A.D., Ankara, Prof. Dr. A 52-year-old man presented with decreased vision in his left eye. Visual acuity was hand motions and fundus examination revealed serous elevation at central macula. During fundus fluorescein angiography, smokestack focal leakage arised from the early hyperfluorescent focus. Mean central macular thickness was found to be 565 μm by optical coherens tomography. 0.1 ml/2.5 mg intravitreal bevacizumab was applied to the left eye under sterile conditions. At the 1^st month of the treatment visual acuity increased to 0.9-1.0 and subretinal fluid completely resolved at the 3^rd postoperative month. No recurrence was detected at the 9^th postoperative control visit. Intravitreal bevacizumab injection may be effective in selected cases of acute central serous chorioretinopathy having significant visual loss. Keywords : Central serous chorioretinopathy, intravitreal bevacizumab